Jefferies analyst David Windley downgrades Inotiv (NASDAQ:NOTV) from Buy to Hold and lowers the price target from $10 to $8.
January 10, 5:07 PM
Inotiv (NASDAQ:NOTV) reported quarterly sales of $150.45 million which missed the analyst consensus estimate of $152.96 million by 1.64 percent. This is a 400.22 percent increase over sales of $30.08 million the same period last year.
January 3, 4:08 PM
Inotiv's (NASDAQ:NOTV) short percent of float has risen 37.5% since its last report. The company recently reported that it has 2.42 million shares sold short, which is 14.41% of all regular shares that are available for trading.
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
December 12, 2:05 PM
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
December 12, 9:06 AM
Gainers HTG Molecular Diagnostics (NASDAQ:HTGM) stock moved upwards by 170.4% to $1.46 during Monday’s pre-market session. The market…